U.S. Attorney Urges Broad View of Anti-Kickback Law in Allergan Case

The Anti-Kickback Statute should be broadly interpreted as a bar to any kind of payment in exchange for health care services paid for by the government, the U.S. Attorney's Office in Philadelphia argued in a qui tam suit brought against a pharmaceutical company called Allergan.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.